• Publications
  • Influence
Differences Between Women and Men With Recent‐Onset Axial Spondyloarthritis: Results From a Prospective Multicenter French Cohort
TLDR
To clarify sex differences in early axial spondyloarthritis (SpA), a large number of patients with SpA are diagnosed with atypical central giant cell granuloma, a leading complication of multiple sclerosis.
No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment.
TLDR
The treatment had a beneficial effect on biologic inflammation and disease activity, but caused a pro-atherogenic lipid profile, which did not improve after 6 and 12 months of rituximab therapy.
Construction and utilization of a script concordance test as an assessment tool for dcem3 (5th year) medical students in rheumatology
TLDR
An online SCT can be used as an assessment tool for medical students in rheumatology and highlights the active participation of community-based r heumatologists, who accounted for the majority of the 19 experts in the reference panel.
Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis
TLDR
The effects of tocilizumab (TCZ), a humanized anti‐interleukin 6 receptor antibody, on body composition and metabolic profile in patients treated for RA is investigated.
Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases.
TLDR
Although FiRST performs less well in inflammatory rheumatic disease, it can be used by the rheumatologist in clinical practice for patients facing an apparent treatment failure and to rule out a potential FM diagnosis which could interfere with the treatment response.
No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
TLDR
Arterial stiffness was not improved after 6 and 12 months of anti-TNF-α therapy, however, treatment decreased biological inflammation and disease activity without causing any changes in lipid profiles and other traditional cardiovascular risk factors.
Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
TLDR
To study the influence of several factors on clinical response to rituximab (RTX) after 6 months in rheumatoid arthritis (RA) patients, data are collected on serum Ig level, anti–cyclic citrullinated peptide, anti‐CCP, and Epstein‐Barr virus load.
Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
TLDR
The worsening of aortic stiffness found after 6 months of abatacept therapy might be due to an insufficient decrease in systemic inflammation, which is of benefit in reducing cardiovascular risk in RA patients.
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.
TLDR
In this large cohort of RA patients, no significant differences were found in EULAR response to RTX between men and women during the 2-years of follow-up, but there was a previous anti-TNF exposure-dependent effect of gender on remission rate.
...
1
2
3
4
5
...